Lalitha Ramkumar is an associate principal in the Life Sciences Practice at CRA, specializing in strategy consulting.
She works on projects with major pharmaceutical and biologics companies gathering consulting experience in market access, contracting strategy (including innovative contracting), and organizational restructuring.
Prior to joining CRA, she completed her MBA at the National University of Singapore. Her prior work includes attaining FDA and EMA approval status for a biologics plant, and working as an engineering consultant, designing a manufacturing plant from conceptual to construction phase.
In her work with clients, Ms. Ramkumar develops access and value strategy for rare disease categories, assists in organizational restructuring projects (including conceptualizing new structure, to developing strategic priorities, and organizing the transition), and conducts multi-stakeholder primary research.